BMI has long been considered a flawed measure that can over-diagnose or underdiagnose obesity, which is currently defined as ...

DaVita, a comprehensive kidney care provider, is celebrating 25 years of clinical care delivery and leadership in healthcare ...

British Heart Foundation grant funding will provide important clues that could help find earlier interventions ...

Maze Therapeutics aims to raise $100 million in an IPO to fund clinical trials for its kidney and related disease treatments.

Registered dietitian nutritionists caring for patients with chronic kidney disease are frequently challenged to help address ...

Kerenida is currently approved to slow the progression chronic kidney disease associated with type 2 diabetes.

In this video, Jay B. Wish, MD, professor of clinical medicine at Indiana University School of Medicine and chief medical ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...

Intensive blood pressure control in patients with chronic kidney disease showed cardiovascular benefits in real-world ...

Kidney transplantation represents a significant advancement for managing end-stage renal disease (ESRD), offering improved recipient quality of life and ...

Zepbound (tirzepatide) is reshaping the competitive landscape in obesity treatment, challenging Novo Nordisk A/S' (NYSE:NVO) ...

The drug candidate is based on the pentraxin-2 platform. It was also under development for the treatment of chronic kidney disease, kidney fibrosis, radiation-induced oral mucositis and cardiac ...